160 related articles for article (PubMed ID: 11455974)
1. Monitoring minimal residual disease and predicting relapse in APL by quantitating PML-RARalpha transcripts with a sensitive competitive RT-PCR method.
Tobal K; Moore H; Macheta M; Yin JA
Leukemia; 2001 Jul; 15(7):1060-5. PubMed ID: 11455974
[TBL] [Abstract][Full Text] [Related]
2. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia.
Gu BW; Hu J; Xu L; Yan H; Jin WR; Zhu YM; Zhao WL; Niu C; Cao Q; Su XY; Gu J; Ying HY; Chen Y; Xiong SM; Shen ZX; Chen Z; Chen SJ
Hematol J; 2001; 2(5):330-40. PubMed ID: 11920269
[TBL] [Abstract][Full Text] [Related]
3. [Improved RT-PCR for detection of PML/RARalpha fusion gene in rapid diagnosis of acute promyelocytic leukemia].
Liu ZL; Luo JM; Wang FX; Zhang XJ; Du XY; Yao L; Dong ZR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Dec; 11(6):587-90. PubMed ID: 14706140
[TBL] [Abstract][Full Text] [Related]
4. Early detection of relapse by prospective reverse transcriptase-polymerase chain reaction analysis of the PML/RARalpha fusion gene in patients with acute promyelocytic leukemia enrolled in the GIMEMA-AIEOP multicenter "AIDA" trial. GIMEMA-AIEOP Multicenter "AIDA" Trial.
Diverio D; Rossi V; Avvisati G; De Santis S; Pistilli A; Pane F; Saglio G; Martinelli G; Petti MC; Santoro A; Pelicci PG; Mandelli F; Biondi A; Lo Coco F
Blood; 1998 Aug; 92(3):784-9. PubMed ID: 9680345
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and molecular monitoring of acute promyelocytic leukemia using DzyNA reverse transcription-PCR to quantify PML/RARalpha fusion transcripts.
Applegate TL; Iland HJ; Mokany E; Todd AV
Clin Chem; 2002 Aug; 48(8):1338-43. PubMed ID: 12142392
[TBL] [Abstract][Full Text] [Related]
6. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and monitoring of PML-RARalpha-positive acute promyelocytic leukemia by quantitative RT-PCR.
Mokany E; Todd AV; Fuery CJ; Applegate TL
Methods Mol Med; 2006; 125():127-47. PubMed ID: 16502582
[TBL] [Abstract][Full Text] [Related]
8. [Detection of PML/RARalpha gene rearrangement in suspected acute promyelocytic leukemia patients using dual-color fluorescence in situ hybridization on bone marrow smears].
Zhu YL; Wu YF; Pan JL; Xue YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):757-60. PubMed ID: 15631655
[TBL] [Abstract][Full Text] [Related]
9. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
[TBL] [Abstract][Full Text] [Related]
10. [Detection of PML/RARalpha gene transcripts in 46 newly diagnosed acute promyelocytic leukemia patients by real-time quantitative reverse-transcription polymerase chain reaction].
Zhu HH; Liu YR; Qin YZ; Li JL; Chang Y; Wang YZ; Shan FX; Jiang B; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Feb; 15(1):1-5. PubMed ID: 17490509
[TBL] [Abstract][Full Text] [Related]
11. A novel, non-nested reverse-transcriptase polymerase chain reaction (RT-PCR) test for the detection of the t(15;17) translocation: a comparative study of RT-PCR cytogenetics, and fluorescence In situ hybridization.
Rennert H; Golde T; Wilson RB; Spitalnik SL; Van Deerlin VM; Leonard DG
Mol Diagn; 1999 Sep; 4(3):195-209. PubMed ID: 10553020
[TBL] [Abstract][Full Text] [Related]
12. Pulsed ATRA as single therapy restores long-term remission in PML-RARalpha-positive acute promyelocytic leukemia patients: real time quantification of minimal residual disease. A pilot study.
Visani G; Buonamici S; Malagola M; Isidori A; Piccaluga PP; Martinelli G; Ottaviani E; Grafone T; Baccarani M; Tura S
Leukemia; 2001 Nov; 15(11):1696-700. PubMed ID: 11681409
[TBL] [Abstract][Full Text] [Related]
13. Using quantification of the PML-RARalpha transcript to stratify the risk of relapse in patients with acute promyelocytic leukemia.
Santamaría C; Chillón MC; Fernández C; Martín-Jiménez P; Balanzategui A; García Sanz R; San Miguel JF; González MG
Haematologica; 2007 Mar; 92(3):315-22. PubMed ID: 17339180
[TBL] [Abstract][Full Text] [Related]
14. The significance of minimal residual disease in patients with t(15;17).
Grimwade D
Best Pract Res Clin Haematol; 2002 Mar; 15(1):137-58. PubMed ID: 11987921
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a droplet digital PCR assay for the evaluation of PML-RARα fusion transcripts in acute promyelocytic leukemia.
Jiang XW; Chen SZ; Zhu XY; Xu XX; Liu Y
Mol Cell Probes; 2020 Oct; 53():101617. PubMed ID: 32585184
[TBL] [Abstract][Full Text] [Related]
16. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
Lang L; Li HM; Liu H; Wang YM; Zhang XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR.
Rossi V; Levati L; Biondi A
Methods Mol Med; 2006; 125():115-26. PubMed ID: 16502581
[TBL] [Abstract][Full Text] [Related]
18. Monitoring PML-RARalpha in acute promyelocytic leukemia.
Jurcic JG
Curr Oncol Rep; 2003 Sep; 5(5):391-8. PubMed ID: 12895391
[TBL] [Abstract][Full Text] [Related]
19. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse.
Tobal K; Newton J; Macheta M; Chang J; Morgenstern G; Evans PA; Morgan G; Lucas GS; Liu Yin JA
Blood; 2000 Feb; 95(3):815-9. PubMed ID: 10648391
[TBL] [Abstract][Full Text] [Related]
20. Influence of bcr-3 PML-RARα transcript on outcome in Acute Promyelocytic Leukemia patients of Kashmir treated with all-trans retinoic acid and/or arsenic tri-oxide.
Baba SM; Shah ZA; Pandith AA; Dil-Afroze ; Jan A; Mir KA; Aziz SA; Ahmad Z
Cancer Genet; 2019 Feb; 231-232():14-21. PubMed ID: 30803552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
